Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Nang Kuang Pharmaceutical Co., Ltd. (1752) Financial Statements

Nang Kuang Pharmaceutical Co., Ltd. Financial Overview

Nang Kuang Pharmaceutical Co., Ltd.'s market cap is currently NT$3.02B. The company's EPS TTM is NT$2.03; its P/E ratio is 16.07; and it has a dividend yield of 5.35%. Nang Kuang Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 2.16BNT$ 2.20BNT$ 2.15BNT$ 1.94BNT$ 1.78B
Gross ProfitNT$ 768.86MNT$ 747.79MNT$ 755.56MNT$ 694.90MNT$ 594.47M
Operating IncomeNT$ 295.67MNT$ 307.55MNT$ 259.91MNT$ 417.67MNT$ 233.76M
EBITDANT$ 478.81MNT$ 491.69MNT$ 402.70MNT$ 591.75MNT$ 418.04M
Net IncomeNT$ 243.95MNT$ 243.41MNT$ 198.41MNT$ 352.00MNT$ 196.11M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 345.67MNT$ 303.37MNT$ 378.48MNT$ 402.51MNT$ 418.41M
Total AssetsNT$ 3.82BNT$ 3.81BNT$ 3.86BNT$ 3.58BNT$ 3.43B
Total DebtNT$ 655.95MNT$ 638.45MNT$ 605.96MNT$ 409.50MNT$ 533.54M
Net DebtNT$ 310.28MNT$ 336.90MNT$ 227.49MNT$ 8.30MNT$ 116.42M
Total LiabilitiesNT$ 1.33BNT$ 1.39BNT$ 1.48BNT$ 1.17BNT$ 1.19B
Stockholders' EquityNT$ 2.48BNT$ 2.42BNT$ 2.38BNT$ 2.41BNT$ 2.24B
Cash Flow
Free Cash FlowNT$ 183.03MNT$ -59.49MNT$ 41.87MNT$ 275.02MNT$ 396.89M
Operating Cash FlowNT$ 464.08MNT$ 466.43MNT$ 342.61MNT$ 369.19MNT$ 556.63M
Investing Cash FlowNT$ -281.94MNT$ -372.39MNT$ -329.51MNT$ -109.85MNT$ -291.48M
Financing Cash FlowNT$ -138.02MNT$ -170.97MNT$ -35.77MNT$ -275.31MNT$ -114.48M

Currency in TWD

Nang Kuang Pharmaceutical Co., Ltd. Earnings and Revenue History

0800M1.6B2.4B5 %10 %15 %20 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Nang Kuang Pharmaceutical Co., Ltd. Liabilities to Assets

01.5B3B4.5B30 %33 %36 %39 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Nang Kuang Pharmaceutical Co., Ltd. Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Nang Kuang Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

0.20.30.40.50.60.70.8Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >